Shenyang Northern Hospital

This study looks at a new approach for people with acute coronary syndrome who have both high risk of blood clots and high risk of bleeding. After getting a special drug-coated stent, some patients will take blood thinners for only one month instead of the usual 12 months. The go…

This study tests whether colchicine, a drug used for gout, can slow the buildup of plaque in heart arteries. It includes 120 adults aged 40-85 who recently had a heart attack and have a specific gene variant (TET2-CHIP). Researchers will measure plaque changes using CT scans over…

This study tests whether adding an extra ablation step to the standard procedure helps people with persistent atrial fibrillation stay in normal heart rhythm longer. About 320 adults aged 18 to 75 with persistent AFib will be randomly assigned to receive either standard ablation …

This study tests whether dapagliflozin, a drug typically used for diabetes, can reduce inflammation in the heart arteries of people who have had a heart attack but do not have diabetes or heart failure. About 110 participants will receive either the drug plus standard care or sta…

This study compares two blood thinners, bivalirudin and heparin, in over 5,000 heart patients who are at high risk of bleeding and need a procedure to open blocked arteries (PCI). The goal is to see if bivalirudin reduces serious complications like death, heart attack, stroke, or…

This study involves 3,500 adults with acute coronary syndrome who have received a heart stent and are at high risk for bleeding. Researchers will test a new quality control system to see if it helps doctors better manage blood thinner therapy, balancing clot prevention with bleed…